🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 19 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/05/2010 14,00 14,00 12,60 12,80 -9,86% 10,00% 29.470
19/05/2010 14,20 14,70 13,50 14,20 +3,65% 8,45% 39.310
18/05/2010 13,30 13,80 13,00 13,70 +3,01% 6,02% 33.500
17/05/2010 13,70 13,90 12,80 13,30 -2,21% 8,03% 24.110
14/05/2010 14,90 14,90 13,30 13,60 -9,93% 10,74% 40.850
13/05/2010 14,90 15,10 14,20 15,10 +2,03% 6,04% 33.670
12/05/2010 14,00 15,10 13,80 14,80 +8,82% 9,29% 34.040
11/05/2010 13,40 14,00 13,00 13,60 +0,74% 7,46% 25.130
10/05/2010 13,60 14,40 13,40 13,50 +4,65% 7,35% 38.790
07/05/2010 12,60 13,00 12,20 12,90 +3,20% 6,35% 51.180
06/05/2010 13,40 13,80 12,00 12,50 -6,02% 13,43% 58.280
05/05/2010 13,60 13,90 12,60 13,30 -4,32% 9,56% 51.990
04/05/2010 14,40 14,90 13,50 13,90 -8,55% 9,72% 79.230
03/05/2010 15,30 15,30 14,50 15,20 -0,65% 5,23% 51.610
30/04/2010 15,50 15,60 14,70 15,30 -1,29% 5,81% 36.090
29/04/2010 14,70 15,50 14,70 15,50 +5,44% 5,44% 52.280
28/04/2010 14,70 15,40 14,70 14,70 -3,29% 4,76% 35.970
27/04/2010 14,10 16,00 14,00 15,20 +7,80% 14,18% 139.850
26/04/2010 14,30 14,30 13,20 14,10 +7,63% 7,69% 68.930
23/04/2010 13,30 13,50 13,00 13,10 +1,55% 3,76% 35.710
22/04/2010 12,80 13,40 12,50 12,90 -1,53% 7,03% 30.360
21/04/2010 12,90 13,30 12,50 13,10 +1,55% 6,20% 55.260
20/04/2010 11,80 13,00 11,60 12,90 +8,40% 11,86% 75.900
19/04/2010 13,00 13,00 11,90 11,90 -8,46% 8,46% 76.510
16/04/2010 13,60 13,60 11,80 13,00 +3,17% 13,24% 102.060
15/04/2010 13,50 13,60 12,60 12,60 -5,97% 7,41% 83.100
14/04/2010 11,70 14,40 11,70 13,40 +12,61% 23,08% 260.410
13/04/2010 11,60 12,10 11,40 11,90 +0,85% 6,03% 36.300
12/04/2010 11,70 12,30 11,50 11,80 +4,42% 6,84% 71.750
09/04/2010 11,90 11,90 11,20 11,30 -3,42% 5,88% 68.020